Gastrointestinal Cancer News

Plasma 25-hydroxyvitamin D levels of 30 ng/mL or higher appeared associated with longer pancreatic cancer survival, according to an analysis of five U.S. prospective cohort studies.

Lifestyle choices can contribute considerably to a person’s cancer risk, as well the outcomes they achieve after they are diagnosed with a malignancy.

Researchers from The Institute of Cancer Research in London have identified five new genes potentially associated with colorectal cancer and concluded that all major colorectal cancer risk genes have now likely been identified.

The risk for recurrent venous thromboembolism appeared low for patients with upper extremity deep vein thrombosis and almost nonexistent for patients with upper extremity superficial vein thrombosis, according to the results of a prospective diagnostic management study.

CDC researchers estimate that U.S. health care facilities have the capacity to meet the National Colorectal Cancer Roundtable’s goal of screening at least 80% of adults aged 50 to 75 years for colorectal cancer by 2018.

Routine colorectal cancer screening should continue to be performed among adults aged 50 to 75 years, according to an updated recommendation from the U.S. Preventive Services Task Force.

James P. Allison, PhD, chair of the department of immunology and executive director of the immunotherapy platform at MD Anderson Cancer Center in Houston, discusses toxicities related to immune-based strategies to treat cancer.

In this video, Mark S. Friedman, MD, of the Moffitt Cancer Center, discusses genetic and environmental risk factors that may increase the risk for developing colon cancer.

CHICAGO — Candace Johnson, PhD, president and CEO of Roswell Park Cancer Institute, discusses how research in immunotherapy and genomics can lead to tailored personalized treatments at the ASCO Annual Meeting.

Patients with hepatitis B virus infection treated with Baraclude had an unexpected lower incidence of hepatocellular carcinoma over time, although the risk for hepatocellular carcinoma in this patient population still persisted, according to the results of a retrospective study.